On November 1, the EU-funded doctoral network ‘ComeInCell’ (Condensates at Membrane Scaffolds – Integrated Systems as Synthetic Cell Compartments) was launched, which supports early-career researchers in biomedicine and biotechnology. From INM, Dr. Oskar Staufer, head of the Immuno-Materials research group at INM, is involved in the project. Together with a doctoral student, he will conduct research at the interface between artificial systems and natural cells.
Staufer is one of 14 leading researchers from nine countries dedicating themselves to developing synthetic models within the project. These models aim to replicate the behavior of natural cells as accurately as possible and are being developed using biophysics, nanotechnology, biochemistry, and bioengineering. The project group’s objective is to gain valuable insights into diseases and explore new applications, such as cell-based therapies and non-invasive drug carriers. The program supports 17 doctoral students, offering them comprehensive training with international placements and workshops. In addition to intensive research work, participants gain insight into industry sectors ranging from biotechnology to software development and actively contribute to scientific publications. In this way, “ComeInCell” combines high-level training and research, paving the way for future innovations at the interface between science and application.